Dementia can be a real snake lurking in the brain of seniors who happen to be our loved ones. Is their memory merely slipping with their added years, or do they really have a cognitive impairment? It’s a tough question for many families. As a member of a family with several instances of dementia, I can attest to that.
Quick tests used in primary care settings to identify whether people are likely to have dementia may often be wrong, according to a study published in the November 28, 2018, online issue of Neurology® Clinical Practice, an official journal of the American Academy of Neurology.
The tests, called brief cognitive assessments, evaluate thinking and memory skills. They help doctors decide who may benefit from a full diagnostic assessment for dementia. The three tests examined in this study were the Mini-Mental State Examination, which looks at orientation to time and place and the ability to remember words, the Memory Impairment Screen, which focuses on the ability to remember words, and Animal Naming, which involves naming as many animals as possible in 60 seconds. Continue reading
At the risk of repeating myself I have a strong interest in any form of dementia and especially Alzheimer’s Disease as I have had at least three close family members succumb – and I am a senior citizen. the folowing is from the University of Washington School of Medicine.
Alzheimer’s disease is difficult to diagnose as well as treat, but researchers now have a promising new screening tool using the window to the brain: the eye.
A study of 3,877 randomly selected patients found a significant link between three degenerative eye diseases – age-related macular degeneration, diabetic retinopathy and glaucoma – and Alzheimer’s disease.
The results offer physicians a new way to detect those at higher risk of this disorder, which causes memory loss and other symptoms of cognitive decline. Continue reading
Studying DNA from more than 1.5 million people, an international team of researchers — led by Washington University School of Medicine in St. Louis and the University of California, San Francisco — has identified points of DNA that increase the risk of cardiovascular disease and also heighten the risk for Alzheimer’s disease, according to an article in Neuroscience News.
Scientists have long been aware of connections between variations of the APOE gene, which is involved in cholesterol and lipid metabolism, and Alzheimer’s disease. That gene is known to double the risk for Alzheimer’s disease in some patients and increase risk by up to 12 times in others. But in the new study, the researchers identified other DNA points that also appear to be involved both in cardiovascular disease risk and the risk for Alzheimer’s. Continue reading
We are eating less; moving more and hopefully living longer, but it is imperative that we have a fully functioning brain or our work will be in vain.
A simple and inexpensive word recall test accurately predicted whether people had elevated brain levels of beta-amyloid. Scientists hope this non-invasive stress test that puts pressure on memory–similar to how an exercise stress test checks cardiovascular health–could help identify subtle signs of cognitive impairment that may have previously been missed by standard memory tests.
An NIA-supported team of researchers led by Dr. David Loewenstein of the Center for Cognitive Neurosciences and Aging and the University of Miami Miller School of Medicine developed the Loewenstein-Acevedo Scales for Semantic Interference and Learning (LASSI-L) test. Their preliminary findings were published in the September 4, 2018 issue of Neurology.
British researchers found that people exposed to increased levels of air pollution had 40 percent higher chances of developing dementia.
Air pollution is an established risk factor for heart disease/stroke and respiratory disease, but its potential role in neurodegenerative diseases, such as dementia, isn’t as clear.
The researchers used carefully calculated estimates of air and noise pollution across Greater London to assess potential links with new dementia diagnoses.
They looked at patient data on 131,000 Londoners aged 50 to 79, and based on their residential postcodes, the researchers estimated their yearly exposure to air pollutants. These were specifically nitrogen dioxide, fine particulate matter and ozone, as well as proximity to heavy traffic and road noise, using modelling methods validated with recorded measurements. Continue reading
I feel very strongly about smoking. This is one of those Captain Obvious things to me. It astounds me that anyone who can read will continue to smoke.
The following is excerpted from my Page – How many ways does smoking harm you? Check it out for chapter and verse on the multi-faceted damage that smoking does to your body.
Tobacco use is the single largest cause of preventable cause of death in the United States.
On average people who smoke die about 10 years sooner than non-smokers. The New England Journal of Medicine.
Smoking triples the risk for cataracts and is also a risk factor for macular degeneration and its response to treatment. Dr. Nicholas Volpe, Tarry Professor and Chairman Department of Opthalmology Feinberg School of Medicine Northwestern University
The American Cancer Society estimates that in 2014 about 224,000 new cases of lung cancer and 159,260 cancer deaths caused by tobacco use. The overall survival rate for those with lung cancer, sadly, remains at around 15%. You have less than one chance in six of surviving. Continue reading
You don’t have to be a senior to suffer from cognitive impairment. Here are some hopefully helpful hints for self-assessment from the Alzheimer’s Association.
With three cases of Alzheimer’s Disease or dementia in my family I have serious interest in all variations of cognitive impairment. Hence, this latest work from Washington University School of Medicine.
It may be possible in the future to screen patients for Alzheimer’s disease using an eye exam.
Using technology similar to what is found in many eye doctors’ offices, researchers at Washington University School of Medicine in St. Louis have detected evidence suggesting Alzheimer’s in older patients who had no symptoms of the disease.
Their study, involving 30 patients, is published Aug. 23 in the journal JAMA Ophthalmology. Continue reading
I have talked a lot about Alzheimer’s Disease and dementia over the past eight years, so when I ran across this explanation from the Mayo Clinic, I thought I would share it with you.
These terms are often used interchangeably, but they actually have very different meanings. Dementia is not a specific disease. It’s an overall term, sometimes referred to as an umbrella term, which describes a wide range of symptoms. These symptoms impact a person’s ability to perform everyday activities independently. Common symptoms include:
A decline in memory
Changes in thinking skills
Poor judgment and reasoning skills
Decreased focus and attention
Changes in language and communication skills
Alzheimer’s disease is one type of dementia, but it’s not the only one. There are many different types and causes of dementia, including:
Lewy body dementia
Parkinson’s disease dementia
Alzheimer’s disease, however, is the most well-known and common form of dementia but not everyone with dementia has Alzheimer’s disease.
If you have been reading this blog for a while you are aware that I have a particular focus on the brain afflictions – dementia and its move common manifestation, Alzheimer’s. Three members on both sides of my family suffered from a form of dementia. While there is no cure or preventative for Alzheimer’s, it seems that exercise is our best chance of possessing a functioning brain in our old age. Hence, my focus on movement of every kind. Now, it seems that we may be getting a new arrow in our quiver to fight mental illness.
Researchers report tau pathology can be reversed in Alzheimer’s patients with the help of a drug. Their study reveals reversing tau pathology in mouse models of dementia resulted in a reversal of cognitive deficits in spatial learning.
Compared with untreated animals, tau mice that had received zileuton performed significantly better on the tests. Their superior performance suggested a successful reversal of memory deficiency. NeuroscienceNews.com image is in the public domain.
Reversing memory deficits and impairments in spatial learning is a major goal in the field of dementia research. A lack of knowledge about cellular pathways critical to the development of dementia, however, has stood in the way of significant clinical advance. But now, researchers at the Lewis Katz School of Medicine at Temple University (LKSOM) are breaking through that barrier. They show, for the first time in an animal model, that tau pathology – the second-most important lesion in the brain in patients with Alzheimer’s disease – can be reversed by a drug.
“We show that we can intervene after disease is established and pharmacologically rescue mice that have tau-induced memory deficits,” explained senior investigator Domenico Praticò, MD, Scott Richards North Star Foundation Chair for Alzheimer’s Research, Professor in the Departments of Pharmacology and Microbiology, and Director of the Alzheimer’s Center at Temple at LKSOM. The study, published online in the journal Molecular Neurobiology, raises new hope for human patients affected by dementia. Continue reading
As a senior (with dementia in his family tree) who often finds himself searching for words, I was fascinated by this study. Mental glitches can be scary. It’s nice to find out that there isn’t anything wrong with your brain.
Speakers hesitate or make brief pauses filled with sounds like “uh” or “uhm” mostly before nouns. Such slow-down effects are far less frequent before verbs, as UZH researchers working together with an international team have now discovered by looking at examples from different languages.
When we speak, we unconsciously pronounce some words more slowly than others, and sometimes we make brief pauses or throw in meaningless sounds like “uhm”. Such slow-down effects provide key evidence on how our brains process language. They point to difficulties when planning the utterance of a specific word. Continue reading
It’s good to see that exercise is being considered as one of the tools in dealing with cognitive decline in seniors. Eat less; move more; live longer. You don’t have to wait till you are in your senior years to practice them.
A comprehensive program providing older people at risk of dementia with healthy eating guidance, exercise, brain training, and management of metabolic and vascular risk factors appears to slow down cognitive decline, according to the first ever randomized controlled trial of its kind, published in The Lancet.
In the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) study, researchers led by Professor Miia Kivipelto from the Karolinska Institutet in Stockholm, Sweden, National Institute for Health and Welfare in Helsinki, and University of Eastern Finland, assessed the effects on brain function of a comprehensive intervention aimed at addressing some of the most important risk factors for age-related dementia, such as high body-mass index and heart health. Continue reading
People with moderate to severe mid-life anxiety may face a greater risk of dementia in later life, suggests an analysis of the available published evidence led by University College London (UCL) and University of Southampton researchers and published in BMJ Open. But as yet, it’s not clear whether treatment for anxiety could curb dementia risk, say the researchers.
“We need more research to find out what impact anxiety treatment might have on dementia risk – whether that’s through pharmacological intervention, or talking therapies or treatments based on mindfulness or meditation, which are known to help reduce anxiety,” said the study’s lead author, Dr Natalie Marchant (UCL Psychiatry).
A mounting body of evidence suggests that mental illness may be associated with dementia in older age, but it’s not clear if it represents initial (prodromal) symptoms before fully fledged disease or acts as an independent risk factor. Continue reading
This is kind of a yin/yang thing with exercise vs rest. Just as I write about the myriad benefits of exercise regularly here, it seems there are almost as many ways that not getting enough sleep damages us. If you would like to learn more, check out my Page – How important is a good night’s sleep?
Losing just one night of sleep led to an immediate increase in beta-amyloid, a protein in the brain associated with Alzheimer’s disease, according to a small, new study by researchers at the National Institutes of Health (NIH). In Alzheimer’s disease, beta-amyloid proteins clump together to form amyloid plaques, a hallmark of the disease.
While acute sleep deprivation is known to elevate brain beta-amyloid levels in mice, less is known about the impact of sleep deprivation on beta-amyloid accumulation in the human brain. The study is among the first to demonstrate that sleep may play an important role in human beta-amyloid clearance.
“This research provides new insight about the potentially harmful effects of a lack of sleep on the brain and has implications for better characterizing the pathology of Alzheimer’s disease,” said George F. Koob, Ph.D., director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, which funded the study.
Beta-amyloid is a metabolic waste product present in the fluid between brain cells. In Alzheimer’s disease, beta-amyloid clumps together to form amyloid plaques, negatively impacting communication between neurons.
Researchers have published a new study framework that defines Alzheimer’s disease by brain changes, not symptoms.
“NIA-AA Research Framework: Towards a Biological Definition of Alzheimer’s Disease” was published in the April 2018 issue of Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. First author Clifford R. Jack, Jr., M.D., of Mayo Clinic Rochester, MN and colleagues propose shifting the definition of Alzheimer’s disease in living people – for use in research – from the current one, based on cognitive changes and behavioral symptoms with biomarker confirmation, to a strictly biological construct. This represents a major evolution in how we think about Alzheimer’s.
In 2011, the Alzheimer’s Association (AA) and the National Institute on Aging (NIA) at the U.S. National Institutes of Health convened experts to update the diagnostic guidelines for Alzheimer’s disease. NeuroscienceNews.com image is in the public domain.
Understanding and effectively treating Alzheimer’s disease and other dementias may be the most difficult challenge for the medical/scientific community this century. The field has experienced monumental challenges developing new and effective drug therapies, not the least of which was the discovery that – until recently – clinical trials were conducted where up to 30% of participants did not have the Alzheimer’s disease-related brain change targeted by the experimental drug. Continue reading
Dementia affects the person diagnosed but also raises fears for siblings and children. Here are the facts.
I have three cases of Alzheimer’s/dementia on both sides of my family, including mother, aunt and grandfather. So, I am extremely sensitive to any information on the subject of cognition and aging. One of the aspects of Alzheimer’s that few people consider, until a loved one becomes afflicted, is that the relatives and people who care about the person suffer greatly as they see a person they loved deteriorate mentally and physically before their eyes. It also raises the specter of – what about me? Will I get it, too?
Here is a good no nonsense discussion from Harvard Men’s Health Watch.
Alzheimer’s disease represents a personal health crisis, but it’s also a family concern. What does it mean for your children or siblings if you are diagnosed with Alzheimer’s? What does it mean for you if a close relative develops the condition?
“People think that if their dad or aunt or uncle had Alzheimer’s disease, they are doomed. But, no, that’s not true,” says Dr. Gad Marshall, assistant professor of neurology at Harvard Medical School. “Even though family history adds to the overall risk, age still usually trumps it quite a bit. It means your risk is higher, but it’s not that much higher, if you consider the absolute numbers.”
Family history by the numbers
Studies of family history say that if you have a close relative who has been diagnosed with Alzheimer’s disease—the most common form of dementia in older adults—your risk increases by about 30%. This is a relative risk increase, meaning a 30% hike in your existing risk. Continue reading